β-carotene supplementation for patients with low baseline levels and decreased risks of total and prostate carcinoma

Cancer

Volumn 86, Issue 9, 1999, Pages 1783-1792

  Cook, Nancy R ^a,d   Stampfer, Meir J ^a,b   Ma, Jing ^a   Manson, JoAnn E ^a,b   Sacks, Frank M ^a,b   Buring, Julie E ^a,b   Hennekens, Charles H ^a,b,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c Division of Preventive Medicine ^*  (United States)

^d Division of Preventive Medicine   (United States)

Author keywords

carotene; Case control studies; Neoplasms; Prostatic neoplasms

Indexed keywords

ACETYLSALICYLIC ACID; BETA CAROTENE;

ADULT; ARTICLE; CANCER PREVENTION; CANCER RISK; CARDIOVASCULAR DISEASE; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PHYSICIAN; PRIORITY JOURNAL; PROSTATE CARCINOMA; RANDOMIZED CONTROLLED TRIAL; RISK MANAGEMENT;

ADULT; AGED; AGED, 80 AND OVER; BETA CAROTENE; CASE-CONTROL STUDIES; COLONIC NEOPLASMS; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; EPIDEMIOLOGIC STUDIES; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; LYMPHOMA; MALE; MELANOMA; MIDDLE AGED; PROSTATIC NEOPLASMS; RISK; SMOKING;

EID: 0033230952     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19991101)86:9<1783::AID-CNCR21>3.0.CO;2-N     Document Type: Article

References (33)

1. Manson JE, Jonas MA, Hunter DJ, Buring JE, Hennekens CH. Prospective cohort studies of vitamins and cancer. In: Bray GA, Ryan DH, editors. Vitamins and cancer prevention. Pennington Center Nutrition Series. Vol. 3. Baton Rouge, LA: Louisiana University Press, 1993;87-109.
2. Van Poppel G. Epidemiologic evidence for β-carotene in prevention of cancer and cardiovascular disease. Eur J Clin Nutr 1996;50(Suppl 3):S57-61.
3. Peto R, Doll R, Buckley JD, Sporn MB. Can dietary beta-carotene materially reduce human cancer rates? Nature 1981;290:201-9.
4. Hennekens CH. Antioxidant vitamins and cancer. Am J Med 1994;97(Suppl 3A):2S-4S.
5. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group. The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1029-35.
6. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, et al. Effects of a combination of beta-carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996;334:1150-5.
7. Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR, et al. Lack of effect of long-term supplementation with beta-carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996;334: 1145-9.
8. Hennekens CH. Issues in the design and conduct of clinical trials. J Natl Cancer Inst 1984;73:1473-6.
9. Blot WJ, Li J-Y, Taylor PR, Guo W, Dawsey S, Wang G-Q, et al. Nutritional intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 1993;85:1483-92.
10. Albanes D, Heinonen OP, Taylor PR, Virtamo J, Edwards BK, Rautalahti M, et al. α-tocopherol and β-carotene supplements and lung cancer incidence in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study: effects of base-line characteristics and study compliance. J Natl Cancer Inst 1996;88:1560-70.
11. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, et al. Risk factors for lung cancer and for intervention effects in CARET, the beta-carotene and retinol efficacy trial. J Natl Cancer Inst 1996;88:1550-9.
12. The Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med 1989; 321:129-35.
13. Gann PH, Hennekens CH, Stampfer MJ. A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. JAMA 1995;273:289-94.
14. Gann PH, Hennekens CH, Ma J, Longcope C, Stampfer MJ. Prospective study of sex hormone levels and risk of prostate cancer. J Natl Cancer Inst 1996;88:1118-26.
15. Catalona WJ, Avioli LV. Diagnosis, staging and surgical treatment of prostatic carcinoma. Arch Intern Med 1987;147: 361-3.
16. SAS Institute Inc. SAS/STAT Software: changes and enhancements through Release 6.12. Cary, NC: SAS Institute Inc., 1997.
17. Breslow NE, Day NE. Statistical methods in cancer research. I. The analysis of case-control studies. IARC Scientific Pub No. 32. Lyon: International Agency for Research on Cancer, 1980.
18. Heinonen OP, Albanes D, Virtamo J, Taylor PR, Huttunen JK, Hartman AM, et al. Prostate cancer and supplementation with α-tocopherol and β-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst 1998;90:440-6.
19. Stryker WS, Kaplan LA, Stein EA, Stampfer MJ, Sober A, Willett WC. The relation of diet, cigarette smoking, and alcohol consumption to plasma beta-carotene and alpha-tocopherol levels. Am J Epidemiol 1988;127:283-96.
20. Nierenberg DW, Stukel TA, Baron JA, Dain BJ, Greenberg ER, and the Skin Cancer Prevention Study Group. Determinants of plasma levels of beta-carotene and retinol. Am J Epidemiol 1989;130:511-21.
21. Goodman GE, Thornquist M, Kestin M, Metch B, Anderson G, Omenn GS, and CARET coinvestigators. The association between participant characteristics and serum concentrations of β-carotene, retinol, retinyl palmitate, and α-tocopherol among participants in the Carotene and Retinol Efficacy Trial (CARET) for prevention of lung cancer. Cancer Epidemiol Biomarkers Prev 1996;5:815-21.
22. Hossain MZ, Zhang L-X, Gibson DFC, Bertram JS. A mechanistic basis for the actions of retinoids and carotenoids as chemopreventive agents. In: Bray GA, Ryan DH, editors. Vitamins and cancer prevention. Pennington Center Nutrition Series. Vol. 3. Baton Rouge, LA: Louisiana University Press, 1993:53-70.
23. Dorgan JF, Schatzkin A. Antioxidant micronutrients in cancer prevention. Hematol Oncol Clin North Am 1991;5:43-68.
24. Wald NJ, Thompson SG, Densem JW, Boreham J, Bailey A. Serum beta-carotene and subsequent risk of cancer: results from the BUPA Study. Br J Cancer 1988;57:428-33.
25. Stähelin HB, Gey KF, Eichholzer M, Lüdin E. β-carotene and cancer prevention: the Basel Study. Am J Clin Nutr 1991;53: 265S-9S.
26. Willett WC, Polk BF, Underwood BA, Stampfer MJ, Pressel S, Rosner B, et al. Relation of serum vitamins A and E and carotenoids to the risk of cancer. N Engl J Med 1984;310: 430-4.
27. Knekt P, Aromaa A, Maatela J, Aaron R-V, Nikkari T, Hakama M, et al. Serum vitamin A and subsequent risk of cancer: cancer incidence follow-up of the Finnish Mobile Clinic Health Examination Survey. Am J Epidemiol 1990;132:857-70.
28. Shibata A, Paganini-Hill A, Ross RK, Henderson BE. Intake of vegetables, fruits, beta-carotene, vitamin C and vitamin supplements and cancer incidence among the elderly: a prospective study. Br J Cancer 1992;66:673-9.
29. Daviglus ML, Dyer AR, Persky V, Chavez N, Drum M, Goldberg J, et al. Dietary beta-carotene, vitamin C, and risk of prostate cancer: results from the Western Electric Study. Epidemiology 1996;7:472-7.
30. Giovannucci E, Ascherio A, Rimm EB, Stampfer MJ, Colditz GA, Willett WC. Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst 1995;87:1767-76.
31. Key TJ, Silcocks PB, Davey GK, Appleby PN, Bishop DT. A case-control study of diet and prostate cancer. Br J Cancer 1997;76:678-87.
32. Hsing AW, Comstock GW, Abbey H, Polk BF. Serologic precursors of cancer. Retinol, carotenoids, and tocopherol and risk of prostate cancer. J Natl Cancer Inst 1990;82:941-6.
33. Nomura AMY, Stemmermann GN, Lee J, Craft NE. Serum micronutrients and prostate cancer in Japanese Americans in Hawaii. Cancer Epidemiol Biomarkers Prev 1997; 6:487-91.